Despite sputum cytology not being an effective screening method to achieve early lung cancer diagnosis [55], subsequent studies have shown that mutations associated with lung cancer, such as in Kras and p53, are detectable in the sputum of patients with this disease [56]. Here, TP53 is linked to lung cancer.